H Bryan Brewer

28.2k total citations · 6 hit papers
152 papers, 21.8k citations indexed

About

H Bryan Brewer is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, H Bryan Brewer has authored 152 papers receiving a total of 21.8k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Surgery, 73 papers in Endocrinology, Diabetes and Metabolism and 56 papers in Molecular Biology. Recurrent topics in H Bryan Brewer's work include Diabetes, Cardiovascular Risks, and Lipoproteins (69 papers), Lipoproteins and Cardiovascular Health (56 papers) and Cholesterol and Lipid Metabolism (33 papers). H Bryan Brewer is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (69 papers), Lipoproteins and Cardiovascular Health (56 papers) and Cholesterol and Lipid Metabolism (33 papers). H Bryan Brewer collaborates with scholars based in United States, France and Germany. H Bryan Brewer's co-authors include James I. Cleeman, Scott M. Grundy, Claude Lenfant, Sidney C. Smith, Sidney C. Smith, C. Noel Bairey Merz, Luther T. Clark, Donald B. Hunninghake, Neil J. Stone and Richard C. Pasternak and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

H Bryan Brewer

152 papers receiving 20.7k citations

Hit Papers

Implications of Recent Clinical Trials for the National C... 2001 2026 2009 2017 2004 2004 2004 2001 2003 1000 2.0k 3.0k 4.0k 5.0k

Peers

H Bryan Brewer
Gerd Assmann Germany
H Bryan Brewer
Citations per year, relative to H Bryan Brewer H Bryan Brewer (= 1×) peers Gerd Assmann

Countries citing papers authored by H Bryan Brewer

Since Specialization
Citations

This map shows the geographic impact of H Bryan Brewer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Bryan Brewer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Bryan Brewer more than expected).

Fields of papers citing papers by H Bryan Brewer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Bryan Brewer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Bryan Brewer. The network helps show where H Bryan Brewer may publish in the future.

Co-authorship network of co-authors of H Bryan Brewer

This figure shows the co-authorship network connecting the top 25 collaborators of H Bryan Brewer. A scholar is included among the top collaborators of H Bryan Brewer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Bryan Brewer. H Bryan Brewer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schaefer, Ernst J., Bela F. Asztalos, Tomáš Vaisar, et al.. (2025). High Density Lipoprotein Particle Composition, Functionality, Deficiency, and Atherosclerotic Cardiovascular Disease Risk: A Review. Current Atherosclerosis Reports. 27(1). 62–62. 3 indexed citations
2.
Calvert, Peter, Mark T Mills, H Bryan Brewer, et al.. (2024). Remote rhythm monitoring using a photoplethysmography smartphone application after cardioversion for atrial fibrillation. European Heart Journal - Digital Health. 5(4). 461–468. 3 indexed citations
3.
Nicholls, Stephen J., A. Michael Lincoff, Philip J. Barter, et al.. (2015). Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial. American Heart Journal. 170(6). 1061–1069. 67 indexed citations
4.
Basso, Federica, Lita A. Freeman, Charles Joyce, et al.. (2006). Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited. Journal of Lipid Research. 48(1). 114–126. 51 indexed citations
5.
Neufeld, Edward B., John A. Stonik, Stephen J. Demosky, et al.. (2004). The ABCA1 Transporter Modulates Late Endocytic Trafficking. Journal of Biological Chemistry. 279(15). 15571–15578. 159 indexed citations
6.
González‐Navarro, Herminia, Zengxuan Nong, Marcelo Amar, et al.. (2004). The Ligand-binding Function of Hepatic Lipase Modulates the Development of Atherosclerosis in Transgenic Mice. Journal of Biological Chemistry. 279(44). 45312–45321. 27 indexed citations
7.
Ikewaki, Katsunori, Loren A. Zech, H Bryan Brewer, & Daniel J. Rader. (2002). Comparative in vivo metabolism of apolipoproteins E2 and E4 in heterozygous apoE2/4 subjects. Journal of Laboratory and Clinical Medicine. 140(5). 369–374. 15 indexed citations
8.
Lambert, Gilles, Naohiko Sakai, Boris Vaisman, et al.. (2001). Analysis of Glomerulosclerosis and Atherosclerosis in Lecithin Cholesterol Acyltransferase-deficient Mice. Journal of Biological Chemistry. 276(18). 15090–15098. 100 indexed citations
9.
Föger, Bernhard, et al.. (1997). Plasma Phospholipid Transfer Protein. Journal of Biological Chemistry. 272(43). 27393–27400. 128 indexed citations
10.
Applebaum‐Bowden, Deborah, Junji Kobayashi, Vikram S. Kashyap, et al.. (1996). Hepatic lipase gene therapy in hepatic lipase-deficient mice. Adenovirus-mediated replacement of a lipolytic enzyme to the vascular endothelium.. Journal of Clinical Investigation. 97(3). 799–805. 59 indexed citations
11.
Klein, Hanns‐Georg, Nicolas Duverger, John J. Albers, et al.. (1995). In Vitro Expression of Structural Defects in the Lecithin-Cholesterol Acyltransferase Gene. Journal of Biological Chemistry. 270(16). 9443–9447. 24 indexed citations
12.
Ikewaki, Katsunori, Masato Nishiwaki, Takuya Sakamoto, et al.. (1995). Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency.. Journal of Clinical Investigation. 96(3). 1573–1581. 69 indexed citations
13.
Reblin, Tjark, Daniel J. Rader, Ulrike Beisiegel†, Heiner Greten, & H Bryan Brewer. (1992). Correlation of apolipoprotein(a) isoproteins with Lp(a) density and distribution in fasting plasma. Atherosclerosis. 94(2-3). 223–232. 35 indexed citations
14.
Fojo, S S & H Bryan Brewer. (1992). Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C‐II. Journal of Internal Medicine. 231(6). 669–677. 84 indexed citations
15.
Shibusawa, Yōichi, et al.. (1992). Counter-current chromatography of lipoproteins with a polymer phase system using the cross-axis synchronous coil planet centrifuge. Journal of Chromatography A. 596(1). 118–122. 13 indexed citations
16.
Malekzadeh, Sonya, Frederick A. Dressler, Jeffrey M. Hoeg, H Bryan Brewer, & William C. Roberts. (1991). Left atrial endocardial lipid deposits and absent to minimal arterial lipid deposits in familial hyperchylomicronemia. The American Journal of Cardiology. 67(16). 1431–1434. 3 indexed citations
17.
Nichols, William C., Richard E. Gregg, H Bryan Brewer, & Merrill D. Benson. (1990). A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics. 8(2). 318–323. 133 indexed citations
18.
Potkin, Benjamin N., Jeffrey M. Hoeg, William E. Connor, et al.. (1988). Aneurysmal coronary artery disease in cerebrotendinous xanthomatosis. The American Journal of Cardiology. 61(13). 1150–1152. 19 indexed citations
19.
Jahn, C., Ernst J. Schaefer, L Taam, et al.. (1985). Lipoprotein abnormalities in primary biliary cirrhosis. Gastroenterology. 89(6). 1266–1278. 41 indexed citations
20.
Jahn, C., Ernst J. Schaefer, L Taam, et al.. (1985). Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification.. PubMed. 89(6). 1266–78. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026